Karen L. Smith - Aug 18, 2023 Form 4 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Role
Director
Signature
/s/ Karen L. Smith
Stock symbol
AUPH
Transactions as of
Aug 18, 2023
Transactions value $
$0
Form type
4
Date filed
8/21/2023, 04:19 PM
Previous filing
Jun 14, 2023
Next filing
Jun 6, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AUPH Restricted Stock Units Award $0 +17.9K $0.00 17.9K Aug 18, 2023 Common Stock 17.9K Direct F1
transaction AUPH Stock Option (right to buy) Award $0 +29K $0.00 29K Aug 18, 2023 Common Stock 29K $9.49 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest one year from date of grant and have no expiration date. Vested shares will be delivered on August 18, 2024.
F2 The option vests in twelve equal installments commencing on September 18, 2023.